Family · Pharmaceutical analytical standards
Sulbactam
A beta-lactamase inhibitor patented in 1977 and in use since 1986 alongside ampicillin: it sacrifices itself by binding the enzymes bacteria use to destroy beta-lactam antibiotics, thus protecting its partner. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Although it was created as a 'shield', it has antibacterial activity of its own against Acinetobacter baumannii: in 2023 it was approved in the United States paired with durlobactam precisely against this bacterium.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
